1. Home
  2. NPKI vs FTRE Comparison

NPKI vs FTRE Comparison

Compare NPKI & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPKI
  • FTRE
  • Stock Information
  • Founded
  • NPKI 1932
  • FTRE 1996
  • Country
  • NPKI United States
  • FTRE United States
  • Employees
  • NPKI N/A
  • FTRE N/A
  • Industry
  • NPKI Metal Fabrications
  • FTRE Medical Specialities
  • Sector
  • NPKI Industrials
  • FTRE Health Care
  • Exchange
  • NPKI Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • NPKI 1.1B
  • FTRE 864.4M
  • IPO Year
  • NPKI N/A
  • FTRE N/A
  • Fundamental
  • Price
  • NPKI $12.76
  • FTRE $11.63
  • Analyst Decision
  • NPKI Strong Buy
  • FTRE Hold
  • Analyst Count
  • NPKI 3
  • FTRE 9
  • Target Price
  • NPKI $14.17
  • FTRE $13.31
  • AVG Volume (30 Days)
  • NPKI 952.2K
  • FTRE 1.2M
  • Earning Date
  • NPKI 10-30-2025
  • FTRE 11-05-2025
  • Dividend Yield
  • NPKI N/A
  • FTRE N/A
  • EPS Growth
  • NPKI N/A
  • FTRE N/A
  • EPS
  • NPKI 0.38
  • FTRE N/A
  • Revenue
  • NPKI $259,372,000.00
  • FTRE $2,759,900,000.00
  • Revenue This Year
  • NPKI $21.14
  • FTRE $0.47
  • Revenue Next Year
  • NPKI $9.42
  • FTRE N/A
  • P/E Ratio
  • NPKI $33.62
  • FTRE N/A
  • Revenue Growth
  • NPKI 25.65
  • FTRE 1.88
  • 52 Week Low
  • NPKI $4.76
  • FTRE $3.97
  • 52 Week High
  • NPKI $14.00
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • NPKI 56.73
  • FTRE 58.91
  • Support Level
  • NPKI $12.12
  • FTRE $10.89
  • Resistance Level
  • NPKI $12.87
  • FTRE $12.07
  • Average True Range (ATR)
  • NPKI 0.58
  • FTRE 0.93
  • MACD
  • NPKI -0.09
  • FTRE 0.09
  • Stochastic Oscillator
  • NPKI 38.33
  • FTRE 64.31

About NPKI NPK International Inc. Common Stock

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: